Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ying Chou

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2011
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scanChao-Hua Chiu, Yi-Chen Yeh, Ko-Han Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2012
Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2Ling-Yen Chung, Shye-Jye Tang, Guang-Huan Sun, et al.
Journal of the Chinese Medical Association : JCMA|February 22, 2005
Mucoepidermoid tumors of the lung: analysis of 11 casesChia-Shen Yang, Kuang-Tai Kuo, Teh-Ying Chou, et al.
Cancers|January 11, 2022
Comparative <i>O</i>-GlcNAc Proteomic Analysis Reveals a Role of <i>O</i>-GlcNAcylated SAM68 in Lung Cancer AggressivenessChia-Hung Lin, Chen-Chung Liao, Shu-Ying Wang, et al.
Interactive Cardiovascular and Thoracic Surgery|June 4, 2013
Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?Po-Kuei Hsu, Ling-I Chien, Chien-Sheng Huang, et al.
BMC Cancer|July 4, 2012
The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasisWen-Liang Chen, Kuang-Tai Kuo, Teh-Ying Chou, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 23, 2013
Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinomaPo-Kuei Hsu, Hua-Ling Kao, Hsuan-Yu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformationMuh-Hwa Yang, Wei-Chung Chiang, Teh-Ying Chou, et al.
Oncotarget|November 8, 2017
Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resectionYu-Chung Wu, Nien-Chih Wei, Jung-Jyh Hung, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methodsHua-Lin Kao, Yi-Chen Yeh, Chin-Hsuan Lin, et al.
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2011
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scanChao-Hua Chiu, Yi-Chen Yeh, Ko-Han Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2012
Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2Ling-Yen Chung, Shye-Jye Tang, Guang-Huan Sun, et al.
Journal of the Chinese Medical Association : JCMA|February 22, 2005
Mucoepidermoid tumors of the lung: analysis of 11 casesChia-Shen Yang, Kuang-Tai Kuo, Teh-Ying Chou, et al.
Cancers|January 11, 2022
Comparative <i>O</i>-GlcNAc Proteomic Analysis Reveals a Role of <i>O</i>-GlcNAcylated SAM68 in Lung Cancer AggressivenessChia-Hung Lin, Chen-Chung Liao, Shu-Ying Wang, et al.
Interactive Cardiovascular and Thoracic Surgery|June 4, 2013
Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?Po-Kuei Hsu, Ling-I Chien, Chien-Sheng Huang, et al.
BMC Cancer|July 4, 2012
The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasisWen-Liang Chen, Kuang-Tai Kuo, Teh-Ying Chou, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 23, 2013
Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinomaPo-Kuei Hsu, Hua-Ling Kao, Hsuan-Yu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformationMuh-Hwa Yang, Wei-Chung Chiang, Teh-Ying Chou, et al.
Oncotarget|November 8, 2017
Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resectionYu-Chung Wu, Nien-Chih Wei, Jung-Jyh Hung, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methodsHua-Lin Kao, Yi-Chen Yeh, Chin-Hsuan Lin, et al.
Pageof 20